Y Combinator unveiled one of its most impressive startup batches to date yesterday, featuring big ideas in medicine, finance, and marketplaces. After carefully watching the demos, speaking with founde
20n, one of a wave of biotech-related startups that Y Combinator is starting to fund, is the brainchild of a UC Berkeley professor and a post-doc.
Saurabh Srivastava and J. Christopher Anderson hav